Paronychia in association with indinavir treatment

Amy E. Colson, Paul E. Sax, Marla J. Keller, Barbara K. Turk, Parker T. Pettus, Richard Platt, Peter W. Choo

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

To assess a possible association between antiretroviral treatment and paronychia, we conducted a retrospective cohort study of 288 human immunodeficiency virus-positive protease inhibitor recipients. Indinavir treatment - adjusted for age, sex, CD4 count, diabetes status and other antiretroviral drug exposures - was significantly associated with paronychia of the great toe (hazard ratio 4.7; 95% confidence interval 1.6-13.9).

Original languageEnglish (US)
Pages (from-to)140-143
Number of pages4
JournalClinical Infectious Diseases
Volume32
Issue number1
DOIs
Publication statusPublished - Jan 1 2001
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Colson, A. E., Sax, P. E., Keller, M. J., Turk, B. K., Pettus, P. T., Platt, R., & Choo, P. W. (2001). Paronychia in association with indinavir treatment. Clinical Infectious Diseases, 32(1), 140-143. https://doi.org/10.1086/317546